MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,235,160 | -36.8% | 29,000 | 0.0% | 0.03% | -37.5% |
| Q2 2023 | $6,699,000 | +97.8% | 29,000 | -8.6% | 0.05% | +71.4% |
| Q1 2021 | $3,387,000 | -4.0% | 31,722 | 0.0% | 0.03% | 0.0% |
| Q4 2020 | $3,527,000 | -68.6% | 31,722 | -66.5% | 0.03% | -73.3% |
| Q3 2020 | $11,229,000 | -3.3% | 94,584 | -7.8% | 0.10% | -14.6% |
| Q2 2020 | $11,618,000 | +218.6% | 102,584 | +150.5% | 0.12% | +207.5% |
| Q1 2020 | $3,647,000 | -2.3% | 40,950 | 0.0% | 0.04% | 0.0% |
| Q4 2019 | $3,731,000 | +4.4% | 40,950 | -1.2% | 0.04% | -14.9% |
| Q3 2019 | $3,574,000 | -17.4% | 41,450 | 0.0% | 0.05% | -13.0% |
| Q2 2019 | $4,325,000 | -16.7% | 41,450 | 0.0% | 0.05% | -18.2% |
| Q1 2019 | $5,192,000 | +46.5% | 41,450 | +31.8% | 0.07% | +22.2% |
| Q4 2018 | $3,545,000 | +18.7% | 31,450 | +125.4% | 0.05% | +35.0% |
| Q3 2018 | $2,987,000 | +13.6% | 13,950 | +48.4% | 0.04% | -4.8% |
| Q2 2018 | $2,629,000 | – | 9,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |